These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1341 related items for PubMed ID: 12374492

  • 1. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.
    Mignot E, Lammers GJ, Ripley B, Okun M, Nevsimalova S, Overeem S, Vankova J, Black J, Harsh J, Bassetti C, Schrader H, Nishino S.
    Arch Neurol; 2002 Oct; 59(10):1553-62. PubMed ID: 12374492
    [Abstract] [Full Text] [Related]

  • 2. The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A).
    Bassetti C, Gugger M, Bischof M, Mathis J, Sturzenegger C, Werth E, Radanov B, Ripley B, Nishino S, Mignot E.
    Sleep Med; 2003 Jan; 4(1):7-12. PubMed ID: 14592354
    [Abstract] [Full Text] [Related]

  • 3. A study of the diagnostic utility of HLA typing, CSF hypocretin-1 measurements, and MSLT testing for the diagnosis of narcolepsy in 163 Korean patients with unexplained excessive daytime sleepiness.
    Hong SC, Lin L, Jeong JH, Shin YK, Han JH, Lee JH, Lee SP, Zhang J, Einen M, Mignot E.
    Sleep; 2006 Nov; 29(11):1429-38. PubMed ID: 17162989
    [Abstract] [Full Text] [Related]

  • 4. Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: relationship to cataplexy and HLA DQB1*0602 status.
    Krahn LE, Pankratz VS, Oliver L, Boeve BF, Silber MH.
    Sleep; 2002 Nov 01; 25(7):733-6. PubMed ID: 12405608
    [Abstract] [Full Text] [Related]

  • 5. Validation of the ICSD-2 criteria for CSF hypocretin-1 measurements in the diagnosis of narcolepsy in the Danish population.
    Knudsen S, Jennum PJ, Alving J, Sheikh SP, Gammeltoft S.
    Sleep; 2010 Feb 01; 33(2):169-76. PubMed ID: 20175400
    [Abstract] [Full Text] [Related]

  • 6. Nocturnal rapid eye movement sleep latency for identifying patients with narcolepsy/hypocretin deficiency.
    Andlauer O, Moore H, Jouhier L, Drake C, Peppard PE, Han F, Hong SC, Poli F, Plazzi G, O'Hara R, Haffen E, Roth T, Young T, Mignot E.
    JAMA Neurol; 2013 Jul 01; 70(7):891-902. PubMed ID: 23649748
    [Abstract] [Full Text] [Related]

  • 7. [Comparative analysis of patients with narcolepsy-cataplexy, narcolepsy without cataplexy and idiopathic hypersomnia].
    Martínez-Rodríguez JE, Iranzo A, Casamitjana R, Graus F, Santamaria J.
    Med Clin (Barc); 2007 Mar 17; 128(10):361-4. PubMed ID: 17386240
    [Abstract] [Full Text] [Related]

  • 8. Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy.
    Andlauer O, Moore H, Hong SC, Dauvilliers Y, Kanbayashi T, Nishino S, Han F, Silber MH, Rico T, Einen M, Kornum BR, Jennum P, Knudsen S, Nevsimalova S, Poli F, Plazzi G, Mignot E.
    Sleep; 2012 Sep 01; 35(9):1247-55F. PubMed ID: 22942503
    [Abstract] [Full Text] [Related]

  • 9. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S, Kanbayashi T.
    Sleep Med Rev; 2005 Aug 01; 9(4):269-310. PubMed ID: 16006155
    [Abstract] [Full Text] [Related]

  • 10. CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions.
    Dauvilliers Y, Baumann CR, Carlander B, Bischof M, Blatter T, Lecendreux M, Maly F, Besset A, Touchon J, Billiard M, Tafti M, Bassetti CL.
    J Neurol Neurosurg Psychiatry; 2003 Dec 01; 74(12):1667-73. PubMed ID: 14638887
    [Abstract] [Full Text] [Related]

  • 11. Narcolepsy without cataplexy: 2 subtypes based on CSF hypocretin-1/orexin-A findings.
    Oka Y, Inoue Y, Kanbayashi T, Kuroda K, Miyamoto M, Miyamoto T, Ikeda A, Shimizu T, Hishikawa Y, Shibasaki H.
    Sleep; 2006 Nov 01; 29(11):1439-43. PubMed ID: 17162990
    [Abstract] [Full Text] [Related]

  • 12. HLA DQB1*06:02 negative narcolepsy with hypocretin/orexin deficiency.
    Han F, Lin L, Schormair B, Pizza F, Plazzi G, Ollila HM, Nevsimalova S, Jennum P, Knudsen S, Winkelmann J, Coquillard C, Babrzadeh F, Strom TM, Wang C, Mindrinos M, Fernandez Vina M, Mignot E.
    Sleep; 2014 Oct 01; 37(10):1601-8. PubMed ID: 25197808
    [Abstract] [Full Text] [Related]

  • 13. HLA-DQB1 allele and hypocretin in Korean narcoleptics with cataplexy.
    Jeong JH, Hong SC, Shin YK, Han JH, Lee SP.
    J Korean Med Sci; 2007 Feb 01; 22(1):127-31. PubMed ID: 17297265
    [Abstract] [Full Text] [Related]

  • 14. CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome.
    Kanbayashi T, Kodama T, Kondo H, Satoh S, Inoue Y, Chiba S, Shimizu T, Nishino S.
    Sleep; 2009 Feb 01; 32(2):181-7. PubMed ID: 19238805
    [Abstract] [Full Text] [Related]

  • 15. CSF hypocretin-1 levels and clinical profiles in narcolepsy and idiopathic CNS hypersomnia in Norway.
    Heier MS, Evsiukova T, Vilming S, Gjerstad MD, Schrader H, Gautvik K.
    Sleep; 2007 Aug 01; 30(8):969-73. PubMed ID: 17702265
    [Abstract] [Full Text] [Related]

  • 16. Hypocretin (orexin) deficiency in narcolepsy and primary hypersomnia.
    Ebrahim IO, Sharief MK, de Lacy S, Semra YK, Howard RS, Kopelman MD, Williams AJ.
    J Neurol Neurosurg Psychiatry; 2003 Jan 01; 74(1):127-30. PubMed ID: 12486284
    [Abstract] [Full Text] [Related]

  • 17. Sleep disturbances and hypocretin deficiency in Niemann-Pick disease type C.
    Vankova J, Stepanova I, Jech R, Elleder M, Ling L, Mignot E, Nishino S, Nevsimalova S.
    Sleep; 2003 Jun 15; 26(4):427-30. PubMed ID: 12841368
    [Abstract] [Full Text] [Related]

  • 18. Traditional biomarkers in narcolepsy: experience of a Brazilian sleep centre.
    Coelho FM, Pradella-Hallinan M, Pedrazzoli M, Soares CA, Fernandes GB, Gonçalves AL, Tufik S, Bittencourt LR.
    Arq Neuropsiquiatr; 2010 Oct 15; 68(5):712-5. PubMed ID: 21049180
    [Abstract] [Full Text] [Related]

  • 19. [Narcolepsy-cataplexy].
    Deflandre E, Roelants F, Cambron L, Poirrier R.
    Rev Med Liege; 2002 Aug 15; 57(8):519-27. PubMed ID: 12405025
    [Abstract] [Full Text] [Related]

  • 20. Monozygotic twins concordant for narcolepsy-cataplexy without any detectable abnormality in the hypocretin (orexin) pathway.
    Khatami R, Maret S, Werth E, Rétey J, Schmid D, Maly F, Tafti M, Bassetti CL.
    Lancet; 2004 Apr 10; 363(9416):1199-200. PubMed ID: 15081654
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 68.